Current concepts and significance of estrogen receptor β in prostate cancer

被引:53
作者
Hartman, Johan [2 ,3 ]
Stroem, Anders [1 ]
Gustafsson, Jan-Ake [1 ,4 ]
机构
[1] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA
[2] Karolinska lnstitutet, Dept Pathol & Oncol, S-17176 Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Clin Pathol & Cytol, Radiumhemmet, S-17176 Stockholm, Sweden
[4] Karolinska Inst, Dept BioSci & Nutr, Novum, S-14157 Huddinge, Sweden
关键词
Estrogen receptor beta; Prostate cancer; Phytoestrogens; Prostate cancer prevention; Targeted therapies; ER-BETA; BREAST-CANCER; RAT PROSTATE; EXPRESSION; ANDROGEN; ALPHA; APOPTOSIS; GROWTH; ADENOCARCINOMA; LOCALIZATION;
D O I
10.1016/j.steroids.2012.07.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An increasing amount of evidence points at important roles for estrogen receptors in prostate carcinogenesis and progression. Of the two estrogen receptors, estrogen receptor beta is the most prominent within the prostate gland. Although there is much yet to be known, the findings from the discovery of the receptor in 1996 until now point at a role of the receptor in maintaining differentiation and reducing cellular proliferation in the prostate. Moreover, estrogen receptor beta is the main target for phytoestrogens. perhaps at least partially explaining the difference in incidence of prostate cancer in the Western world compared to Asia where the intake of soy-based, phytoestrogen-rich food is higher. The tumor suppressive capability of estrogen receptor beta makes it a promising drug target for the treatment and prevention of prostate cancer. This review will focus on different aspects of estrogen receptor signaling and prostate cancer. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1262 / 1266
页数:5
相关论文
共 68 条
[1]   An overview on 5α-reductase inhibitors [J].
Aggarwal, Saurabh ;
Thareja, Suresh ;
Verma, Abhilasha ;
Bhardwaj, Tilak Raj ;
Kumar, Manoj .
STEROIDS, 2010, 75 (02) :109-153
[2]   Androgen receptor action in hormone-dependent and recurrent prostate cancer [J].
Agoulnik, Irina U. ;
Weigel, Nancy L. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (02) :362-372
[3]   Phenoxodiol Inhibits Growth of Metastatic Prostate Cancer Cells [J].
Aguero, Martin F. ;
Venero, Marina ;
Brown, David M. ;
Smulson, Mark E. ;
Espinoza, Luis A. .
PROSTATE, 2010, 70 (11) :1211-1221
[4]   Effect of Dutasteride on the Risk of Prostate Cancer. [J].
Andriole, Gerald L. ;
Bostwick, David G. ;
Brawley, Otis W. ;
Gomella, Leonard G. ;
Marberger, Michael ;
Montorsi, Francesco ;
Pettaway, Curtis A. ;
Tammela, Teuvo L. ;
Teloken, Claudio ;
Tindall, Donald J. ;
Somerville, Matthew C. ;
Wilson, Timothy H. ;
Fowler, Ivy L. ;
Rittmaster, Roger S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (13) :1192-1202
[5]   Estrogen receptor expression in prostate cancer and premalignant prostatic lesions [J].
Bonkhoff, H ;
Fixemer, T ;
Hunsicker, I ;
Remberger, K .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (02) :641-647
[6]   Progesterone receptor expression in human prostate cancer: Correlation with tumor progression [J].
Bonkhoff, H ;
Fixemer, T ;
Hunsicker, I ;
Remberger, K .
PROSTATE, 2001, 48 (04) :285-291
[7]  
CARTER HB, 1990, PROG CLIN BIOL RES, V350, P129
[8]   Phase II study of fulvestrant (Faslodex®) in castration resistant prostate cancer [J].
Chadha, Manpreet K. ;
Ashraf, Umeer ;
Lawrence, David ;
Tian, Lili ;
Levine, Ellis ;
Silliman, Carrie ;
Escott, Paul ;
Payne, Valencia ;
Trump, Donald L. .
PROSTATE, 2008, 68 (13) :1461-1466
[9]  
Chang WY, 1999, PROSTATE, V40, P115
[10]   Mesenchymal-epithelial interactions: past, present, and future [J].
Cunha, Gerald R. .
DIFFERENTIATION, 2008, 76 (06) :578-586